2023 annual financial data
Biodexa Pharmaceuticals plc - American Depositary Shares 2023 Operating margin
Biodexa Pharmaceuticals plc - American Depositary Shares 2023 operating margin…
Direct answer
Operating margin was -2,103.41%.
Operating income was -8,014,000 GBP and net income was -7,079,000 GBP.
Operating cash flow was -6,826,000 GBP.
Get free Biodexa Pharmaceuticals plc - American Depositary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 381,000 GBP
- Operating income
- -8,014,000 GBP
- Net income
- -7,079,000 GBP
- Operating cash flow
- -6,826,000 GBP
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Biodexa Pharmaceuticals plc - American Depositary Shares financial years